Warby Parker Inc.
NYSE:WRBYMedical - Instruments & Supplies
+$0.92 today
- Market cap
- $3.07B
- Beta
- 1.97
- P/E (TTM)
- 2305.1
- EPS (TTM)
- $0.01
Volume 5.90M
Average 2.81M
WRBY Weighted Avg Shares (Diluted)
Average shares outstanding including dilutive securities, used to calculate diluted EPS.
Warby Parker Inc.NYSE: WRBY
Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026
Weighted avg shares (diluted) grows in line with its trailing trend
Q2 FY2026 weighted avg shares (diluted) of 125.75M shares rose 2.6% year over year, ahead of the +2.0% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.2% from the prior quarter. Over 3 fiscal years it compounded at +2.9% a year.
Context
- Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +2.6% holds above the trailing-twelve-month pace of +2.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares (Diluted) history
Shares · from the income statement
- Latest · FY2025
- 125.1M USD
- Year-over-year change
- +3.9%
- 4-year CAGR
- +2.4%
| Period | Period end | Weighted Avg Shares (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 125.1M | +3.9% |
| FY2024 | 2024-12-31 | 120.39M | +2.6% |
| FY2023 | 2023-12-31 | 117.39M | +2.1% |
| FY2022 | 2022-12-31 | 114.94M | +1.2% |
| FY2021 | 2021-12-31 | 113.62M | — |
Weighted Avg Shares (Diluted) vs competitors
How WRBY compares with its peers on the latest reported figures
- WRBY's LTM Jun 2026 weighted avg shares (diluted) of 124.85M shares is the 4th highest of the 10 companies compared; the peer median is 67.93M shares.
- Its year-over-year change of +2.0% is the 3rd highest of 10, against a peer median of +0.9%.
- Over three fiscal years its annual growth of +2.9% compares with a peer median of +1.2%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | 374.23M | +0.9% | +1.2% | |
| LTM Mar 2026 | 199.58M | -1.4% | -2.6% | |
CONConcentra Group Holdings Parent, Inc. | LTM Sep 2026 | 127.9M | +0.1% | +0.4% |
| LTM Jun 2026 | 124.85M | +2.0% | +2.9% | |
| LTM Jun 2026 | 103.77M | +17.0% | +12.2% | |
| LTM Mar 2026 | 67.93M | +1.0% | +5.7% | |
| LTM Jun 2026 | 46.64M | -6.6% | -2.7% | |
| LTM Jul 2026 | 34.83M | -1.6% | +2.2% | |
| LTM Jun 2026 | 24.9M | +1.4% | +1.4% | |
| LTM Mar 2026 | 23.32M | +2.1% | +1.1% | |
| Peer median (excluding WRBY) | 67.93M | +0.9% | +1.2% | |
Competitors are the stored peer set for WRBY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 540.8M | 598.11M | 669.77M | 771.32M | 871.91M |
| Cost of Revenue | 223.05M | 257.05M | 304.54M | 344.48M | 401.33M |
| Gross Profit | 317.75M | 341.06M | 365.22M | 426.83M | 470.58M |
| Gross Margin | 58.8% | 57.0% | 54.5% | 55.3% | 54.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 461.41M | 452.27M | 421.57M | 440.05M | 475.92M |
| Operating Expenses | 461.41M | 452.27M | 437.22M | 456.95M | 475.92M |
| Depreciation & Amortization | 21.87M | 31.86M | 38.55M | 45.87M | 50.28M |
| EBITDA | (122.14M) | (78.03M) | (24.21M) | 26.35M | 53.32M |
| EBITDA Margin | -22.6% | -13.0% | -3.6% | 3.4% | 6.1% |
| Operating Income | (143.66M) | (111.2M) | (72M) | (30.11M) | (5.34M) |
| Operating Margin | -26.6% | -18.6% | -10.7% | -3.9% | -0.6% |
| Interest Income | 0 | 1.31M | 9.23M | 10.6M | 8.38M |
| Interest Expense | 347K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (347K) | 1.31M | 9.23M | 10.6M | 8.38M |
| Income Before Tax | (144.01M) | (109.9M) | (62.76M) | (19.52M) | 3.04M |
| Pre-Tax Margin | -26.6% | -18.4% | -9.4% | -2.5% | 0.3% |
| Income Tax Expense | 263K | 497K | 433K | 875K | 1.4M |
| Net Income | (144.27M) | (110.39M) | (63.2M) | (20.39M) | 1.64M |
| Net Margin | -26.7% | -18.5% | -9.4% | -2.6% | 0.2% |
| EPS (Basic) | (1.39) | (0.96) | (0.54) | (0.17) | 0.01 |
| EPS (Diluted) | (1.39) | (0.96) | (0.54) | (0.17) | 0.01 |
| Weighted Avg Shares | 113.62M | 114.94M | 117.39M | 120.39M | 122.67M |
| Weighted Avg Shares (Diluted) | 113.62M | 114.94M | 117.39M | 120.39M | 125.1M |
Warby Parker Inc.
NYSE:WRBY
Intrinsic Alpha fair value
Locked
Current Price
$28.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.